Stocksigma LogoStocksigma Logo

Gland Pharma Approves Internal Corporate Restructuring to Direct US Subsidiary Ownership

Gland Pharma Limited's Board approved the 100% equity acquisition of step-down subsidiary Gland Pharma USA Inc. from Gland Pharma International Pte. Ltd

Gland Pharma Approves Internal Corporate Restructuring to Direct US Subsidiary Ownership

Gland Pharma Ltd 路 Others (Uncategorized) 路 13 Sept 2026, 10:02 pm

Gland Pharma Approves Internal Corporate Restructuring to Direct US Subsidiary Ownership Gland Pharma Limited's Board approved the 100% equity acquisition of step-down subsidiary Gland Pharma USA Inc. from Gland Pharma International Pte. Ltd. for a cash consideration of USD 5,01,208. The transaction converts Gland US into a direct wholly-owned subsidiary to remove corporate layers and streamline operations, with no material business impact. Incorporated in Mar'22 for pharma marketing and distribution, Gland US posted FY26 turnover of Nil (FY25: USD 87,342; FY24: USD 4,83,808). The transaction is slated for completion by 31st Oct'26.

Original exchange filing (PDF)

More announcements from Gland Pharma Ltd

All Gland Pharma Ltd announcements